FWM
ALIM

Focused Wealth Management’s Alimera Sciences ALIM Stock Holding History

Focused Wealth Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-66
Closed -$285 – 1033
2023
Q4 		$285 Hold
66
– – ﹤0.01% 946
2023
Q3 		$205 Hold
66
– – ﹤0.01% 961
2023
Q2 		$193 Hold
66
– – ﹤0.01% 1001
2023
Q1 		$139 Hold
66
– – ﹤0.01% 995
2022
Q4 		$179 Hold
66
– – ﹤0.01% 1021
2022
Q3 		$0 Hold
66
– – ﹤0.01% 1080
2022
Q2 		$0 Hold
66
– – ﹤0.01% 1109
2022
Q1 		$0 Hold
66
– – ﹤0.01% 1137
2021
Q4 		$0 Hold
66
– – ﹤0.01% 1121
2021
Q3 		$0 Hold
66
– – ﹤0.01% 1128
2021
Q2 		$1K Hold
66
– – ﹤0.01% 902
2021
Q1 		$1K Hold
66
– – ﹤0.01% 885
2020
Q4 		$0 Hold
66
– – ﹤0.01% 923
2020
Q3 		$0 Hold
66
– – ﹤0.01% 889
2020
Q2 		$0 Hold
66
– – ﹤0.01% 846
2020
Q1 		$0 Hold
66
– – ﹤0.01% 791
2019
Q4 		$1K Sell
66
-1
-1% -$6 ﹤0.01% 692
2019
Q3 		$1K Hold
67
– – ﹤0.01% 680
2019
Q2 		$1K Buy
+67
New +$943 ﹤0.01% 713

Other funds holding ALIM

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Focused Wealth Management's ALIM Position: Q1 2024 in Review

Focused Wealth Management sold out of Alimera Sciences (ALIM) in Q1 2024, closing a stake of 66 shares — an estimated $285 sold.

Focused Wealth Management first reported a position in ALIM in Q2 2019 and held it in 19 quarters. The position peaked at $1K in Q2 2021. 39 funds tracked by Wall St. Rank hold ALIM as of Q1 2024.

  • Focused Wealth Management reported no remaining Alimera Sciences position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 66 Alimera Sciences shares in Q1 2024, an estimated $285.
  • Focused Wealth Management first reported a position in Alimera Sciences in Q2 2019 and held it in 19 quarters.
  • Focused Wealth Management's Alimera Sciences position peaked at $1K in Q2 2021.
  • 39 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.